Robert E. Waltermire, Senior VP, Chief Pharma Development at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 2,072 shares at $231.34 ($479K) on 2024-05-21, disclosed to the SEC on 2024-05-23.
Open-market sale of $479k MDGL by Senior VP, Chief Pharma Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $231.34 | 1,036 | $240K | 50.0% |
| 2 | $231.34 | 1,036 | $240K | 50.0% |
| Total | $231.34 avg | 2,072 | $479K | 100% |
| Filing → |
| MDGL | SELL | 2025-01-27 | $35K | — | Filing → |
| MDGL | SELL | 2025-01-17 | $242K | — | Filing → |
| MDGL | SELL | 2024-06-18 | $532K | — | Filing → |